Helsinn v. Teva

Join us on Tuesday, June 11 as Nic Brentlinger discusses the surprising, unanimous Supreme Court decision of Helsinn v. Teva.

Nic will discuss nuances of the phrase “or otherwise available to the public” under Section 102(a)(1) in light of the Supreme Court’s ruling and will give practice tips for how to safeguard technology to ensure protection against inadvertent disclosures.

REGISTER HERE by June 10th at noon.

About the Speaker:

Nic is an attorney at Dinsmore & Shohl with a degree in Chemical Engineering, who previously worked on designing and implementing pharmaceuticals and manufacturing process lines. Nic has a wealth of experience in preparing, filing and prosecuting domestic and international patent applications. His practice involves every step of obtaining protection and managing patent portfolios, from conducting due diligence analysis to handling interference proceedings to drafting right-to-use and invalidity opinions. He also has extensive experience reviewing and drafting licensing agreements, having worked with clients in a variety of industries, including Fortune 500 companies.